Elucidating the cardiac outcomes of irreversible proteasome inhibitor Carfilzomib in in vivo models of HFpEF and HFrEF. Preventive role of Metformin. (31st December 2022)
- Record Type:
- Journal Article
- Title:
- Elucidating the cardiac outcomes of irreversible proteasome inhibitor Carfilzomib in in vivo models of HFpEF and HFrEF. Preventive role of Metformin. (31st December 2022)
- Main Title:
- Elucidating the cardiac outcomes of irreversible proteasome inhibitor Carfilzomib in in vivo models of HFpEF and HFrEF. Preventive role of Metformin
- Authors:
- Efentakis, Panagiotis
Lamprou, Sofia
Varela, Aimilia
Eleni-Dimitra, Papanagnou
Christodoulou, Andriana
Gavriatopoulou, Maria
Davos, Costantinos
Trougkakos, Ioannis
Dimopoulos, Meletios Athanasios
Terpos, Evangelos
Andreadou, Ioanna - Abstract:
- Is Part Of:
- Journal of molecular and cellular cardiology. Volume 173(2022)Supplement
- Journal:
- Journal of molecular and cellular cardiology
- Issue:
- Volume 173(2022)Supplement
- Issue Display:
- Volume 173, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 173
- Issue:
- 2022
- Issue Sort Value:
- 2022-0173-2022-0000
- Page Start:
- 134
- Page End:
- 135
- Publication Date:
- 2022-12-31
- Subjects:
- Cardiology -- Periodicals
Heart Diseases -- Periodicals
Molecular Biology -- Periodicals
Cardiologie -- Périodiques
Cardiology
Electronic journals
Periodicals
616.12 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00222828 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00222828 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/00222828 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.yjmcc.2022.08.263 ↗
- Languages:
- English
- ISSNs:
- 0022-2828
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5020.690000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25128.xml